The effect of social determinants on immunization programs

Human Vaccines & Immunotherapeutics
Aharona Glatman-Freedman, Katherine A Nichols

Abstract

Vaccine preventable diseases have been responsible for a significant portion of childhood mortality in low-income countries, and have been re-emerging in medium- and high-income countries. The effectiveness of routine childhood immunization programs relies on multiple factors. Social determinants have the potential to affect immunization programs around the world, with globalization and ease of communication facilitating their effect. Exploring the types of social determinants affecting immunization efforts in various countries is of great importance to the ability of nations to address them, prevent the spread of disease and lower mortality rates. The social determinants affecting vaccination programs can vary among countries of different income levels, with some social determinants overlapping among these country groups. In this article we explore the various social determinants affecting routine immunization programs in low-, middle- and high-income countries and possible interventions to address them.

References

Jun 1, 1996·Archives of Pediatrics & Adolescent Medicine·D L Wood, N Halfon
Jan 1, 1996·The Pediatric Infectious Disease Journal·S HutchinsS Hadler
Feb 1, 1997·International Journal of Epidemiology·M DeebY Courbage
Oct 3, 1998·Clinical Immunology and Immunopathology·V K SinghV C Yang
Jul 15, 1999·JAMA : the Journal of the American Medical Association·D A SalmonR T Chen
Aug 3, 1999·Pediatrics·J M SantoliV G Coronado
Jun 3, 2000·Health Policy and Planning·D Woodle
Jul 8, 2000·Tropical Medicine & International Health : TM & IH·F NuwahaJ Barenzi
Nov 10, 2001·American Journal of Preventive Medicine·R K ZimmermanM Raymund
Sep 27, 2003·Social Science & Medicine·Rohini P Pande, Abdo S Yazbeck
Apr 9, 2004·BMJ : British Medical Journal·Fariyal F Fikree, Omrana Pasha
Apr 24, 2004·The Journal of Infectious Diseases·Fuyuen Y YipSusan B Redd
Jan 22, 2005·International Journal of Epidemiology·K Robert YaméogoPeter Strebel
May 2, 2006·The Medical Journal of Australia·Christine B Phillips, Mahomed Patel
Dec 14, 2006·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·J François Outreville
Dec 22, 2006·The Medical Journal of Australia·Albert C D TiongBeverley-Ann Biggs
Mar 16, 2007·Journal of Biosocial Science·Stephen Obeng Gyimah
Mar 31, 2007·Vaccine·Alan SmithDavid M Salisbury
Apr 17, 2007·Epidemiology and Infection·C Stein-ZamirE Mendelson
Apr 20, 2007·European Journal of Public Health·Angela DominguezLluís Salleras
May 15, 2007·The New England Journal of Medicine·Alexandra M Stewart
Aug 9, 2007·JAMA : the Journal of the American Medical Association·Grace M LeeTracy A Lieu
Oct 24, 2007·Journal of Immigrant and Minority Health·Victoria H Buelow, Jennifer Van Hook
Oct 24, 2007·Journal of the American Board of Family Medicine : JABFM·Paul HicksXimena Prieto Hicks
Feb 1, 2008·Bulletin of the World Health Organization·Lara J WolfsonJean-Marie Okwo-Bele
May 9, 2008·Journal of the Royal Society of Medicine·Lesley HendersonNicki Thorogood
Jan 10, 2009·International Journal for Equity in Health·Adamson S MuulaEmmanuel Rudatsikira
Aug 25, 2009·American Journal of Law & Medicine·Vivien Davis Tsu
Aug 25, 2009·American Journal of Law & Medicine·Sean McElligott
Aug 26, 2009·Bulletin of the World Health Organization·Rafael ObregónEllyn Ogden
Oct 16, 2009·BMC International Health and Human Rights·Léonard FournRoméo Gansey
Oct 16, 2009·BMC International Health and Human Rights·Philippe DuclosThomas Cherian
Oct 16, 2009·BMC International Health and Human Rights·Daniel J CorsiPrabhat Jha
Oct 16, 2009·BMC International Health and Human Rights·Steven MitchellAnne Cockcroft
Oct 23, 2009·Journal of Community Health·Mary-Christine SullivanCraig Hadley

❮ Previous
Next ❯

Citations

Nov 18, 2016·MMWR. Morbidity and Mortality Weekly Report·Rebecca M CaseyAaron S Wallace
Mar 17, 2016·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Ana Catharina Nunes FernandesRegilda Saraiva dos Reis Moreira-Araújo
May 3, 2018·Human Vaccines & Immunotherapeutics·Olatunji O AdetokunbohCharles S Wiysonge
Feb 21, 2018·The Pediatric Infectious Disease Journal·Joel MasseyDanae Bixler
Mar 28, 2018·Journal of Epidemiology and Community Health·Mohammad Hajizadeh
Nov 21, 2013·Influenza and Other Respiratory Viruses·Laurentiu ZolotuscaJoshua A Mott
Apr 29, 2015·Influenza and Other Respiratory Viruses·Qiu Sue HuangMarc-Alain Widdowson
Jan 17, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Tammy BoyceKatrine Bach Habersaat
Nov 14, 2019·Journal of Racial and Ethnic Health Disparities·Anat Amit AharonOrna Baron-Epel
Aug 19, 2016·Journal of Epidemiology and Community Health·Tim Crocker-BuqueSandra Mounier-Jack
Aug 29, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Rosagemma CilibertiAlessandro Bonsignore
Nov 28, 2019·Israel Journal of Health Policy Research·Aharona Glatman-FreedmanTamy Shohat
Jan 1, 2019·European Journal of Public Health·Vladimir VukovicChiara de Waure
Mar 7, 2021·Vaccines·Martina BarchittaAntonella Agodi
Mar 18, 2021·Chaos, Solitons, and Fractals·Mohammad Qaleh Shakhany, Khodakaram Salimifard
Apr 2, 2021·Future Healthcare Journal·Michael Eb FitzPatrickCaitlin Morgan
Jun 17, 2021·Journal of General Internal Medicine·Daniel J ParenteJennifer Woodward
Aug 28, 2021·International Journal of Environmental Research and Public Health·Shuaa Z AlshammariMohamad Al-Tannir
Sep 21, 2021·PloS One·Maria KyprianidouKonstantinos Giannakou
Oct 14, 2021·Human Vaccines & Immunotherapeutics·Manuel Colomé-HidalgoÁngel Gil de Miguel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.